BLOOMINGTON, Ind. — Governor Eric J. Holcomb today joined executives of Simtra BioPharma Solutions (Simtra) and local officials to break ground on the company’s new state-of-the-art manufacturing facility in Monroe County.
 |
| In February, Simtra announced plans to expand its footprint in Bloomington by building a 150,000-square-foot manufacturing facility to house two high-speed automated isolator syringe fill lines and a new, high-speed isolator vial line equipped with three lyophilizers. The new facility will be supported by a $250 million investment and the creation of hundreds of new jobs.
Life sciences is a vital industry to Indiana’s economy and contributes $95 billion to the state’s economy annually and employs 67,000 people. Life sciences are also a source of venture capital funding with $910 million awarded to dozens of companies in 2022 and 2023.
Based on the company’s plans to create up to 130 jobs, the Indiana Economic Development Corporation committed an investment in Simtra BioPharma Solutions of up to $1.6 million in conditional tax credits. These incentives are performance-based, meaning the company is eligible to claim state benefits once Hoosiers are hired and trained. Monroe County offered additional incentives.
|
“Indiana’s life sciences industry is on a roll,” said Gov. Holcomb. “Simtra’s investment in advancing critical R&D and delivering life-changing pharmaceuticals is not just benefiting people around the world, it’s also growing Indiana’s economy and creating high-quality careers for Hoosiers.”
“This event marks a significant milestone for Simtra BioPharma Solutions, and the Bloomington and Monroe County community that we have been proud to call home for more than 40 years,” said Ray Guidotti, Chief Operating Officer, Simtra BioPharma Solutions. “Our $250+ million investment is a testament to our commitment to meeting the growing demands of our industry and supporting our customers in their mission to deliver life-saving therapies to patients. This investment will create hundreds of jobs, highlighting our dedication to growth, innovation, and excellence. We are building the future of sterile injectable manufacturing, ensuring that Simtra remains at the forefront of our industry.”
Indiana’s life sciences ecosystem has experienced tremendous growth since 2021. In total, since 2021 $11.5 billion in committed capital has flowed into the state through 96 projects and 11,852 committed jobs.
